|
1
|
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
|
J Clin Oncol
|
2006
|
2.60
|
|
2
|
Metastatic melanoma to lymph nodes in patients with unknown primary sites.
|
Cancer
|
2006
|
1.93
|
|
3
|
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
|
Ann Surg Oncol
|
2005
|
1.76
|
|
4
|
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
|
J Clin Oncol
|
2008
|
1.67
|
|
5
|
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
|
J Clin Oncol
|
2002
|
1.65
|
|
6
|
Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
|
Ann Surg Oncol
|
2003
|
1.64
|
|
7
|
Ethnic differences among patients with cutaneous melanoma.
|
Arch Intern Med
|
2006
|
1.63
|
|
8
|
Lymph node ratio predicts disease-specific survival in melanoma patients.
|
Cancer
|
2009
|
1.63
|
|
9
|
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.
|
Ann Surg Oncol
|
2002
|
1.57
|
|
10
|
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.
|
J Invest Dermatol
|
2003
|
1.54
|
|
11
|
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
|
J Clin Oncol
|
2006
|
1.50
|
|
12
|
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
|
J Natl Cancer Inst
|
2003
|
1.42
|
|
13
|
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
|
Clin Cancer Res
|
2005
|
1.38
|
|
14
|
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.
|
Cancer
|
2010
|
1.37
|
|
15
|
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.
|
Cancer
|
2002
|
1.34
|
|
16
|
Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
|
Cancer
|
2004
|
1.30
|
|
17
|
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.
|
Ann Surg Oncol
|
2010
|
1.24
|
|
18
|
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.
|
Cancer
|
2010
|
1.19
|
|
19
|
Invasive squamous cell carcinoma of the skin: defining a high-risk group.
|
Ann Surg Oncol
|
2006
|
1.18
|
|
20
|
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
|
Cancer
|
2006
|
1.15
|
|
21
|
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
|
J Clin Oncol
|
2005
|
1.12
|
|
22
|
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
|
Cancer
|
2006
|
1.11
|
|
23
|
Melanoma adrenal metastasis: natural history and surgical management.
|
Am J Surg
|
2008
|
1.10
|
|
24
|
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.10
|
|
25
|
Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.
|
Carcinogenesis
|
2006
|
1.09
|
|
26
|
ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.
|
Mol Cancer Ther
|
2004
|
1.09
|
|
27
|
Patient with advanced gastric cancer responds twice to the same systemic therapy.
|
Gastrointest Cancer Res
|
2009
|
1.08
|
|
28
|
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.
|
Ann Surg Oncol
|
2009
|
1.08
|
|
29
|
Factors influencing the volume-outcome relationship in gastrectomies: a population-based study.
|
Ann Surg Oncol
|
2007
|
1.06
|
|
30
|
Cost effectiveness of adjuvant interferon in node-positive melanoma.
|
J Clin Oncol
|
2007
|
1.05
|
|
31
|
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
|
Acta Oncol
|
2008
|
1.04
|
|
32
|
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction.
|
Ann Surg Oncol
|
2007
|
1.04
|
|
33
|
Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
|
Oncology (Williston Park)
|
2002
|
1.03
|
|
34
|
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.
|
J Clin Oncol
|
2005
|
1.01
|
|
35
|
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
|
Pharmacogenet Genomics
|
2006
|
1.00
|
|
36
|
The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
|
Cancer
|
2008
|
1.00
|
|
37
|
Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
|
Cancer
|
2002
|
0.99
|
|
38
|
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
|
Cancer
|
2008
|
0.98
|
|
39
|
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
|
Cancer
|
2006
|
0.98
|
|
40
|
Surgical approaches to gastric cancer.
|
J Surg Oncol
|
2012
|
0.98
|
|
41
|
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
|
J Invest Dermatol
|
2006
|
0.97
|
|
42
|
Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
|
Ann Surg Oncol
|
2007
|
0.93
|
|
43
|
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
|
J Natl Cancer Inst
|
2005
|
0.92
|
|
44
|
Giant hepatic hemangioma masquerading as a gastric subepithelial tumor.
|
Gastroenterol Hepatol (N Y)
|
2013
|
0.91
|
|
45
|
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.90
|
|
46
|
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
|
World J Surg Oncol
|
2008
|
0.90
|
|
47
|
Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.
|
J Thorac Cardiovasc Surg
|
2005
|
0.89
|
|
48
|
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.89
|
|
49
|
High-level microsatellite instability in appendiceal carcinomas.
|
Am J Surg Pathol
|
2013
|
0.88
|
|
50
|
Adjuvant irradiation for axillary metastases from malignant melanoma.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.88
|
|
51
|
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
|
Cancer
|
2007
|
0.87
|
|
52
|
Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
|
Ann Surg Oncol
|
2007
|
0.87
|
|
53
|
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.86
|
|
54
|
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
|
Cancer
|
2006
|
0.85
|
|
55
|
Combined-modality therapy for gastric cancer.
|
Semin Surg Oncol
|
2003
|
0.85
|
|
56
|
Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume.
|
Support Care Cancer
|
2013
|
0.84
|
|
57
|
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
|
Melanoma Res
|
2009
|
0.83
|
|
58
|
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer.
|
Cancer
|
2007
|
0.83
|
|
59
|
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
|
Ann Surg Oncol
|
2004
|
0.82
|
|
60
|
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.
|
J Transl Med
|
2010
|
0.82
|
|
61
|
Pneumoperitoneum in the cancer patient.
|
Ann Surg Oncol
|
2007
|
0.81
|
|
62
|
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.
|
Cancer
|
2008
|
0.80
|
|
63
|
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.80
|
|
64
|
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience.
|
Oncology
|
2012
|
0.79
|
|
65
|
Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis.
|
Arch Pathol Lab Med
|
2015
|
0.79
|
|
66
|
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.78
|
|
67
|
Lymphadenectomy for gastric cancer.
|
J Clin Oncol
|
2004
|
0.78
|
|
68
|
Adjuvant and neoadjuvant therapy for gastric cancer.
|
Surg Clin North Am
|
2005
|
0.77
|
|
69
|
Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.
|
J Surg Oncol
|
2002
|
0.77
|
|
70
|
Management of peritoneal carcinomatosis: is an answer at hand?
|
Ann Surg Oncol
|
2003
|
0.77
|
|
71
|
Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
|
Ann Surg
|
2004
|
0.77
|
|
72
|
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed....
|
Ann Surg Oncol
|
2007
|
0.76
|
|
73
|
Peritoneal dissemination of non-carcinoid primary appendiceal cancer.
|
Gynecol Oncol
|
2007
|
0.75
|
|
74
|
Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series.
|
Acta Oncol
|
2012
|
0.75
|
|
75
|
Subaquatic laparoscopy for staging of intraabdominal malignancy.
|
J Am Coll Surg
|
2003
|
0.75
|
|
76
|
Multimodality approaches to localized gastric cancer.
|
J Natl Compr Canc Netw
|
2010
|
0.75
|